As of April 19, 2025, Acumen Pharmaceuticals (ABOS) has a market cap of $54.565 million USD. According to our data, Acumen Pharmaceuticals is ranked No.8010 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $54.56 M |
-47.20%
|
Dec 31, 2024 | $0.10 B |
-55.21%
|
Dec 29, 2023 | $0.23 B |
-28.89%
|
Dec 30, 2022 | $0.32 B |
-20.12%
|
Dec 31, 2021 | $0.41 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Moderna
MRNA
|
$9.56 B |
-0.000 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
-0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$30.36 B |
0.000 M
|
![]() USA
|
![]() Catalyst Pharmaceuticals
CPRX
|
$2.75 B |
0.000 M
|
![]() USA
|
Market Cap | = | ABOS Stock Price | * | ABOS Shares Outstanding |
= | $0.90 | * | 60.57 M | |
= | $54.56 M |